United Kingdom-Leeds: NHS National Framework for Transition products (Axitinib and Eltrombopag)
Details
| Contract Title: | United Kingdom-Leeds: NHS National Framework for Transition products (Axitinib and Eltrombopag) |
| Published Date: | May 2, 2025 |
| Notice Type: | Notice (PriorInformationNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 DLN/DNW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 DLS/DNE: 01/10/2025 to 31/0...